Colorectal CancerPhase 2NCT06617858
Trial of AMB-05X for Patients With ctDNA(+) Colorectal Cancer After Curative-intent Treatment
AMB-05X
39 Phase 2 studies recruiting right now, most recently updated first.
Open the Phase 2 page · a list of only those studies
Triangle is made by Triangle Health, Inc.
Colorectal and anal39 studies
Colorectal CancerPhase 2NCT06617858
AMB-05X
Colorectal CancerPhase 2NCT07235293
DSP107 + Atezolizumab, Fruquintinib
Colorectal Carcinoma Metastatic in the LiverPhase 2NCT06555133
yttrium-90 radioembolization
Colorectal CancerPhase 2NCT06728072
Standard of Care Chemotherapy + Metronidazole, ciprofloxacin, aspirin
Early Rectal CancerPhase 2NCT07735624
Botensilimab, Balstilimab
Anal CancerPhase 2NCT07425054
HPV ctDNA Response based radiation, Chemotherapy, Retifanlimab
Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC)Phase 2NCT06589440
SR-8541A
Colorectal Cancer MetastaticPhase 2NCT07550088Papers
Balstilimab (BAL), Botensilimab (BOT), agenT-797
Small Bowel AdenocarcinomaPhase 2NCT06835387
Nanoliposomal irinotecan, Oxaliplatin, 5 fluorouracil, Leucovorin
Colorectal CancerPhase 2NCT06948448
ONO-4578, Opdivo®, Oxaliplatin, 5-Fluorouracil
Appendiceal Mucinous NeoplasmPhase 2NCT07693452
Metformin
Rectal CancerPhase 2NCT04643366
Chemotherapy, Radiation Therapy
Rectal AdenocarcinomaPhase 2NCT06780787
Balstilimab, Biospecimen Collection, Botensilimab, Capecitabine
Microsatellite Stable Rectal CarcinomaPhase 2NCT06843434
Balstilimab, Botensilimab
Colon CancerPhase 2NCT05239546
Dostarlimab